Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction. JHEP Rep., (4)4:100443, Elsevier BV, April 2022. [PUMA: a disease; HCC, or intelligence; liver multivariable non-alcoholic multimodal ML, artificial WSIs, images; prediction support integration TACE, DICOM, AI, network; deep neural Digital Diagnosis; MVI, transarterial fatty topic_lifescience microvascular convolutional in learning; imaging; Communications invasion; NAFLD, chemoembolisation; hepatocellular Reporting steatohepatitis; Transparent Individual slide machine Prognosis Artificial data for NASH, whole Medicine; TRIPOD, of CNN, and Imaging carcinoma; diagnostic system; model]
Artificial intelligence-based detection of FGFR3 mutational status directly from routine histology in bladder cancer: A possible preselection for molecular testing?. Eur. Urol. Focus, (8)2:472--479, Elsevier BV, März 2022. [PUMA: Artificial intelligence; learning; therapy for Deep mutations; Bladder cancer; Molecular fibroblast receptor testing topic_lifescience growth factor FGFR3]